Lymerix is off the market
April 2002
The Lyme vaccine Lymerix is off the market due to poor sales.
Many factors may have contributed to the low demand. Lymerix is expensive...used in just a few states...and isn't very effective.
It has also gotten a lot of bad press.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote